183 related articles for article (PubMed ID: 35941537)
1. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways.
Zhao M; Wang Y; Zhang Y; Li X; Mi J; Wang Q; Geng Z; Zuo L; Song X; Ge S; Zhang Z; Tang M; Li H; Wang Z; Jiang C; Su F
BMC Gastroenterol; 2022 Aug; 22(1):378. PubMed ID: 35941537
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6.
Zhong D; Lyu X; Fu X; Xie P; Liu M; He F; Huang G
Technol Cancer Res Treat; 2020; 19():1533033820967473. PubMed ID: 33073697
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
[TBL] [Abstract][Full Text] [Related]
4. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
5. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
[TBL] [Abstract][Full Text] [Related]
6. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
[TBL] [Abstract][Full Text] [Related]
8. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
Hong M; Almutairi MM; Li S; Li J
Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
[TBL] [Abstract][Full Text] [Related]
9. LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating CDK6.
Cheng T; Yao Y; Zhang S; Zhang XN; Zhang AH; Yang W; Hou CZ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6208-6219. PubMed ID: 34730201
[TBL] [Abstract][Full Text] [Related]
10. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
11. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
12. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
13. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
[TBL] [Abstract][Full Text] [Related]
14. [FAT1 inhibits cell proliferation of esophageal squamous cell carcinoma through regulating the expression of CDK4/CDK6/CCND1 complex].
Hu XL; Zhai YF; Li GD; Xing JF; Yang J; Bi YH; Wang J; Shi RY
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):14-20. PubMed ID: 29365412
[No Abstract] [Full Text] [Related]
15. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J
Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1205 Suppresses Hepatocellular Carcinoma Cell Proliferation via a CSNK2B/CDK4 Axis.
Li X; Xie S; Xia Q; Yan J; Chen S; Shen J
Technol Cancer Res Treat; 2023; 22():15330338221150544. PubMed ID: 36617978
[No Abstract] [Full Text] [Related]
18. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
19. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
